- Home
- SMXT vs SCLX Comparison
SMXT vs SCLX Comparison
Compare SMXT & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMXT
- SCLX
- Stock Information
- Founded
- SMXT 2008
- SCLX 2011
- Country
- SMXT United States
- SCLX United States
- Employees
- SMXT N/A
- SCLX N/A
- Industry
- SMXT
- SCLX Biotechnology: Pharmaceutical Preparations
- Sector
- SMXT
- SCLX Health Care
- Exchange
- SMXT NYSE
- SCLX Nasdaq
- Market Cap
- SMXT 67.0M
- SCLX 72.5M
- IPO Year
- SMXT 2024
- SCLX N/A
- Fundamental
- Price
- SMXT $1.58
- SCLX $0.45
- Analyst Decision
- SMXT
- SCLX Strong Buy
- Analyst Count
- SMXT 0
- SCLX 3
- Target Price
- SMXT N/A
- SCLX $11.33
- AVG Volume (30 Days)
- SMXT 408.6K
- SCLX 184.3K
- Earning Date
- SMXT 03-05-2025
- SCLX 03-11-2025
- Dividend Yield
- SMXT N/A
- SCLX N/A
- EPS Growth
- SMXT N/A
- SCLX N/A
- EPS
- SMXT N/A
- SCLX N/A
- Revenue
- SMXT $28,793,764.00
- SCLX $55,152,000.00
- Revenue This Year
- SMXT N/A
- SCLX $32.77
- Revenue Next Year
- SMXT N/A
- SCLX $50.71
- P/E Ratio
- SMXT N/A
- SCLX N/A
- Revenue Growth
- SMXT N/A
- SCLX 9.41
- 52 Week Low
- SMXT $0.60
- SCLX $0.38
- 52 Week High
- SMXT $15.88
- SCLX $2.63
- Technical
- Relative Strength Index (RSI)
- SMXT N/A
- SCLX 42.08
- Support Level
- SMXT N/A
- SCLX $0.40
- Resistance Level
- SMXT N/A
- SCLX $0.53
- Average True Range (ATR)
- SMXT 0.00
- SCLX 0.05
- MACD
- SMXT 0.00
- SCLX 0.01
- Stochastic Oscillator
- SMXT 0.00
- SCLX 47.59
About SMXT SOLARMAX TECHNOLOGY INC
SolarMax Technology Inc is an integrated solar and renewable energy company. It operates in two segments namely the United States and China. The United States business includes the sale and installation of photovoltaic and battery backup systems. China operations consist of operating and maintaining solar farm projects and identifying and procuring solar farm projects for resale to third parties. Some of its products are LG Solar Panels, QCELL Solar Panels, Panasonic Solar Panels, and others. The company generates a majority of its revenue from the Solar energy systems.
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.